Abstract

BackgroundToday, breast cancer is one of the most aggressive cancers in women and new cases continue to increase worldwide. The incidence of this tumor is kept under control especially with surgery. In order to reduce mortality we need to detect this life threatening disease at an earlier stage.For two years, we have conducted a study for the identification and characterization of suspicious breast lesions using a new diagnostic technique applied to ultrasonography and mammography called “PhiΦBreast.”MethodsIdentification and characterization of category C4-C5 lesions of the breast with high Predictive Positive PPV value, with a new innovative method called “PhiΦBreast” using the Golden Ratio (Phi, or Φ 1.618...) Fibonacci sequence and a Predictive Algorithm, applied to the ultrasonography and mammography with subsequent deepening with cytological examination using fine needle aspiration (FNAC), according to evaluation criteria of the Breast Imaging Report Data System (BI-RADS) and the American College of Radiology (ACR).Usefulness of this research and the use of this new diagnostic tecnique is to detect the breast cancer in early stage. In addition to develop a classification model of the histological type identified in the section areas and the percentage of probability in relation between the golden spiral and Fibonacci sequence.This amazing intuition and research has given contribution to the new Theory of Spiral Cancer.ResultsWith the use of Golden Ratio and Fibonacci sequence, applied to ultrasonography and mammography, we have experimented and developed a diagnostic map with characteristics of high probability of identifying suspicious lesions at an early stage.We examined 987 women, 55 lesions detected with PhiΦBreast pattern were classified according to BI-RADS descriptors for US-imaging, including morphologic features that had a high predictive value for the malignancy (p <0.001).This innovative diagnostic technique has shown a sensitivity of 95%, a specificity of 97%, a positive predictive value of 97%, and negative predictive value of 96%.The discriminating capacity of PhiΦBreast was significantly better than normal ultrasonography (P < 0,05).Furthermore with a predictive algorithm associated with malignant cytology after FNAC, we have classified different types of potentially life threatening cancers for patients.ConclusionPhiΦBreast could be an important new model diagnostic technique to be applied ultrasound and mammography for detection of malignant lesions of category C4-C5.In diagnostic imaging beyond the identification of a lesion and classification according to the BI-RADS category and the evaluation criteria of the ACR is fundamental to recognize predictively the characteristics of a potentially aggressive tumor.Everything mentioned above, reinforces the concept that the early diagnosis is essential because it allows to remove small tumors and therefore capable of producing more limited metastases than the potential of the most voluminous neoplasm.This way, we could plan an effective cure for the patient.This new model (PhiΦBreast) could represent the cornerstone as an important contribution for early diagnosis of breast cancer.

Highlights

  • Today, breast cancer is one of the most aggressive cancers in women and new cases continue to increase worldwide

  • We examined 987 women, 55 lesions detected with PhiΦBreast pattern were classified according to BI-RADS descriptors for US-imaging, including morphologic features that had a high predictive value for the malignancy (p

  • With a predictive algorithm associated with malignant cytology after fine needle aspiration cytology (FNAC), we have classified different types of potentially life threatening cancers for patients

Read more

Summary

Introduction

Breast cancer is one of the most aggressive cancers in women and new cases continue to increase worldwide. The incidence of this tumor is kept under control especially with surgery. Breast cancer is the most commonly diagnosed cancer among US women. With an estimated 268,600 newly diagnosed women with invasive disease, 48,100 cases of ductal carcinoma in situ (DCIS) in 2019, accounting for approximately 15.2-30% of all new cancer cases among women, with the mortality rate of 16%. The cases of breast cancer diagnosis are around 31,000 a year, with an increasing incidence from southern to the northern Italy [3]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call